BIODEX has a total of 16 patent applications. Its first patent ever was published in 1998. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and medical technology are CARBYLAN THERAPEUTICS INC, HISTOCELL SL and CELLMED AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 4 | |
#3 | Canada | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | France | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Polysaccharides | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Jozefonvicz Jacqueline | 13 |
#2 | Correia Jose | 12 |
#3 | Chaubet Frederic | 10 |
#4 | Jozefowicz Marcel | 9 |
#5 | Huynh Remi | 9 |
#6 | Dahri-Correia Latifa | 8 |
#7 | Petite Herve | 4 |
#8 | Bagheri Rozita | 4 |
#9 | Blanchat Cinderella | 4 |
#10 | Crepin Michel | 4 |
Publication | Filing date | Title |
---|---|---|
WO2007034321A2 | Wound-healing pharmaceutical compositions comprising at least one soluble dextran and at least one platelet-derived growth factor | |
CA2379048A1 | Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative | |
CA2376898A1 | Biologically active material based on an insolubilised dextran derivative and a growth factor | |
FR2809735A1 | Pharmaceutical composition containing at least one polymer associated or conjugated with at least one salt of phenylalkycarboxylic acid, conjugated polymers and their applications | |
EP0990002A1 | Dextran derivatives, preparation method and applications as medicine with specific biological action |